A comparative evaluation of the small leucine-rich proteoglycans of pathological human intervertebral discs.
about
Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degenerationA Histopathological Scheme for the Quantitative Scoring of Intervertebral Disc Degeneration and the Therapeutic Utility of Adult Mesenchymal Stem Cells for Intervertebral Disc Regeneration.Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells.The cellular and molecular biology of the intervertebral disc: A clinician's primerPotential use of human adipose mesenchymal stromal cells for intervertebral disc regeneration: a preliminary study on biglycan-deficient murine model of chronic disc degeneration.The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc.Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.Contaminants in commercial preparations of 'purified' small leucine-rich proteoglycans may distort mechanistic studies.Biglycan: a multivalent proteoglycan providing structure and signalsChondroadherin fragmentation mediated by the protease HTRA1 distinguishes human intervertebral disc degeneration from normal aging.Biochemical composition and turnover of the extracellular matrix of the normal and degenerate intervertebral disc.Small leucine-rich proteoglycans (SLRPs): characteristics and function in the intervertebral disc.Decorin inhibits the proliferation of HepG2 cells by elevating the expression of transforming growth factor-β receptor II.Bedside to bench and back to bedside: Translational implications of targeted intervertebral disc therapeutics.Morphological changes in the human cervical intervertebral disc post trauma: response to fracture-type and degeneration grade over time.
P2860
Q26783031-E40C21F1-26B8-44E9-83C5-202793E607DBQ33755294-E8DBE129-38F8-41D6-B337-CA24C8F45188Q33844611-D614ADA9-3FE3-42B6-9802-5FA5E3E60C2EQ34072144-4623ACB8-A5F1-43E8-86B2-824D8DC79B77Q34468505-E52F7ADC-8093-46A7-8599-F2641D020F0AQ36030540-6DBDB47B-9880-48A6-85B3-151F3AC83C3DQ36190865-2D6D0014-9AD7-420A-904B-1FBE87A06CA4Q36228943-C1871208-5483-4C85-A8A9-D54DF01B81E3Q36481626-55E8C330-B9BF-4A3C-8DE3-8D40E9BB11C6Q36967434-0C3798AF-6A81-4E85-9D27-8552639DED73Q38099552-1CBF0DCE-3F23-4E6B-93C0-06CB53B73F26Q38586849-1FB1E39A-8A6B-4A63-B3F8-1C800F48DDE9Q41195962-5BD8AFC7-B195-4899-9604-AA4A2EF40149Q52718902-7E1FE056-1BE8-40DA-A669-B8567827F394Q52929948-7BA3A658-07A3-4532-B78A-68F58B7DE221
P2860
A comparative evaluation of the small leucine-rich proteoglycans of pathological human intervertebral discs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A comparative evaluation of th ...... al human intervertebral discs.
@ast
A comparative evaluation of th ...... al human intervertebral discs.
@en
type
label
A comparative evaluation of th ...... al human intervertebral discs.
@ast
A comparative evaluation of th ...... al human intervertebral discs.
@en
prefLabel
A comparative evaluation of th ...... al human intervertebral discs.
@ast
A comparative evaluation of th ...... al human intervertebral discs.
@en
P2093
P2860
P1476
A comparative evaluation of th ...... al human intervertebral discs.
@en
P2093
James Melrose
Peter Roughley
Sharon Brown
Stephen M Eisenstein
P2860
P2888
P304
P356
10.1007/S00586-012-2179-1
P478
21 Suppl 2
P577
2012-02-23T00:00:00Z